Telehealth Intervention for Youth With T1DM

August 12, 2016 updated by: Erinn T. Rhodes, Boston Children's Hospital

Telehealth Intervention for Youth With Type 1 Diabetes

Hospitalization of youth with established diabetes is both costly and frequently preventable. Poor glycemic control is a risk factor for hospitalization and is also associated with adolescent age and lower socioeconomic status. This is a randomized, controlled trial for high-risk adolescent youth with T1DM and suboptimal glycemic control with an intervention arm and usual care control arm matched for frequency of contacts. There will be 110 subjects with T1DM and HbA1c>8%, aged 13 to 17 years, recruited from the Diabetes Program at Boston Children's Hospital and followed for 6 months. The intervention will be implemented by a diabetes nurse educator and social worker, who will each have monthly contact with the adolescent and a parent/guardian through a telehealth (videoconference) visit. Care will be guided by a diabetes action plan. Telehealth interventions have been utilized successfully in both adults and youth with diabetes. They facilitate frequent contact with the care team allowing barriers to adherence to be addressed, education to be reinforced, care plans to be updated, and diabetes-specific family support to be provided.

Study Overview

Study Type

Interventional

Enrollment (Actual)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02115
        • Boston Children's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

13 years to 17 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age 13 to 17 years
  • Type 1 diabetes for ≥1 year
  • HbA1c>8%
  • Able to speak and read English (Child)
  • Able to speak and read English (Parent)
  • Parent agrees to participate
  • Parent and child each have email addresses

Exclusion Criteria:

  • Plan to transition diabetes care to a center other than Boston Children's Hospital
  • No visit to Boston Children's Hospital Diabetes Program in year prior to recruitment
  • Current participation in another diabetes-related study with an intervention
  • Living with or related to another study participant
  • Significant psychopathology or medical illness that would limit the subject's ability to provide assent and/or participate in the study procedures as determined by the PI.
  • No internet access

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Telehealth Intervention
Telehealth intervention - 6 months
Monthly videoconference with diabetes nurse educator; Monthly videoconference with social worker; Diabetes action plan;
Active Comparator: Usual care
Usual care control with comparable frequency of contact
Standard diabetes care- typically a visit with a diabetes health care provider every 3 months and referrals to a dietitian or mental health specialist as deemed appropriate; Study participation reminder cards twice per month

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Hemoglobin A1c
Time Frame: baseline and 6 months
Change in hemoglobin A1c over 6 months
baseline and 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
% patients meeting ADA HbA1c target
Time Frame: At 6 months
proportion of patients meeting the American Diabetes Association target for optimal glycemic control in this age group, which is <7.5%
At 6 months
Diabetes-related adverse events
Time Frame: Up to 6 months
number of diabetes-related hospitalizations, ED visits, and episodes of severe hypoglycemia
Up to 6 months
Change in Diabetes self-efficacy
Time Frame: Baseline and 6 months
change over 6 months assessed by questionnaire
Baseline and 6 months
Change in Adherence to diabetes self-management
Time Frame: Baseline and 6 months
change over 6 months assessed by questionnaire
Baseline and 6 months
Change in competence with diabetes skills
Time Frame: Baseline and 6 months
change over 6 months assessed by questionnaire
Baseline and 6 months
Change in Health related quality of life
Time Frame: Baseline and 6 months
change over 6 months assessed by questionnaire
Baseline and 6 months
Change in Diabetes Knowledge
Time Frame: Baseline and 6 months
Change over 6 months assessed by questionnaire
Baseline and 6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Direct medical costs
Time Frame: Up to 6 months
Direct medical costs include planned intervention costs and medical costs that are expected to change as a result of the intervention.
Up to 6 months
Change in diabetes-related family conflict
Time Frame: Baseline and 6 months
assessed by questionnaire
Baseline and 6 months
Change in family responsibility for diabetes tasks
Time Frame: Baseline and 6 months
assessed by questionnaire
Baseline and 6 months
Telehealth intervention satisfaction
Time Frame: At 6 months
satisfaction, engagement, visit characteristics
At 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Erinn T Rhodes, MD, MPH, Boston Children's Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2013

Primary Completion (Actual)

May 1, 2014

Study Completion (Actual)

May 1, 2014

Study Registration Dates

First Submitted

January 28, 2013

First Submitted That Met QC Criteria

January 31, 2013

First Posted (Estimate)

February 4, 2013

Study Record Updates

Last Update Posted (Estimate)

August 15, 2016

Last Update Submitted That Met QC Criteria

August 12, 2016

Last Verified

August 1, 2016

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Type 1 Diabetes Mellitus

Clinical Trials on Telehealth Intervention

3
Subscribe